chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a 65 year old female who on 13-SEP-2007 was vaccinated subcutaneously with Zostavax (Oka/Merck) 0.65 ml.  There was no concomitant medication.  On approximately 22-SEP-2007 the patient experienced redness and swelling from her shoulder to her elbow in the arm she received the vaccination.  She also experienced a fever.  Subsequently, the patient recovered from the events.  Additional information has been requested.
Syncope with 4-5 seconds of increased tone (no clonic movement) following immunizations with hepatitis A and IM Typhoid. Pulse 40 (BP 90/60). No tongue biting, positive incontinence. After Trendelenberg, O2 2l n.p.; no orthostasis. Feels well. Home with father. No post-ictal state. Neurological exam WNL with focal deficits.
Information has been received on 24-OCT-2018 regarding a case in litigation from a lawyer and a female consumer of unknown age. The patient's concurrent conditions, medical history and concomitant medications are unknown. In or about April 2017, the patient received the ZOSTAVAX (lot number and expiration unknown) unknown route for its intended purpose: the prevention of shingles. Shortly thereafter, the patient suffered vision loss in one eye and strokes. As a direct and proximate result of ZOSTAVAX, the patient's symptoms have resulted in physical limitations not present prior to using ZOSTAVAX. The patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of ZOSTAVAX, the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of ZOSTAVAX, the patient suffered serious progressive, permanent and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. The patient has incurred and will continue to incur medical expenses and other economic harm as a direct result of ZOSTAVAX. Vision loss in one eye and strokes were disabling. Upon internal review, vision loss in one eye and strokes were considered to be medically significant. Additional information has been requested.
Small white patch on right site 2-3 mm, pretty small; Little red bumps in left hand/ little red all over the left hand; Hand look odd, the texture is not normal; Little soreness; 8mm white patch in her shoulder, higher the injection site (left arm); This spontaneous case was reported by a dentist (subsequently medically confirmed) and describes the occurrence of PAIN (Little soreness), SKIN REACTION (8mm white patch in her shoulder, higher the injection site (left arm)), ERYTHEMA (Little red bumps in left hand/ little red all over the left hand), SKIN TEXTURE ABNORMAL (Hand look odd, the texture is not normal) and SKIN REACTION (Small white patch on right site 2-3 mm, pretty small) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced PAIN (Little soreness). On 10-Jan-2021, the patient experienced ERYTHEMA (Little red bumps in left hand/ little red all over the left hand) and SKIN TEXTURE ABNORMAL (Hand look odd, the texture is not normal). In January 2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced SKIN REACTION (8mm white patch in her shoulder, higher the injection site (left arm)). On an unknown date, the patient experienced SKIN REACTION (Small white patch on right site 2-3 mm, pretty small). On 07-Jan-2021, PAIN (Little soreness) had resolved. At the time of the report, SKIN REACTION (8mm white patch in her shoulder, higher the injection site (left arm)), ERYTHEMA (Little red bumps in left hand/ little red all over the left hand), SKIN TEXTURE ABNORMAL (Hand look odd, the texture is not normal) and SKIN REACTION (Small white patch on right site 2-3 mm, pretty small) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
12Mar2021 caller reported the tested positive for COVID; This is a spontaneous report from a contactable consumer. A male patient of an unspecified age (Age: 41; Unit: Unspecified) received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 02Mar2021 (Batch/Lot number was not reported) as SINGLE DOSE for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. The reporter stated that he received first dose of vaccine 02Mar2021. On 08Mar2021 he began to have COVID symptoms. 12Mar2021 caller reports the tested positive for COVID. 22Mar2021 patient tested negative for COVID. Reporter would like to know if he can get his second dose tomorrow. The patient underwent lab tests and procedures which included covid-19: positive on 12Mar2021, covid-19: negative on 22Mar2021. The outcome of the event was recovered on 22Mar2021.  Information about lot/batch number has been requested.
6 days s/p vaccination - developed a severe headache, low grade fever, and nausea without other GI symptoms, as well as chest pain without shortness of breath. The discharge summary and consult reports received on 3/11/04 state myopericarditis and aseptic meningitis. At this point he seems to have recovered. However, we cannot be complete sure until after his 2 yr follow-up.
-Development of heart palpitations (July 2021 through present) -shortness of breath (July 2021 - Present)  -sensitive heart rate (heart rate spikes from 70bpm to 100 bpm when standing up)  (on and off between Jan 2022 and present)  - dull aching chest pain (July 2021 - present)  - dizziness/vertigo (November 2021 - present)  - localized headaches (November 2021- present) - inflammation of the stomach/esophagus ( December 2021 - Present)  - Constant belching associated with cardiac pain (December 2021 - present)  - Neuropathy of left foot ( Feb 2021 - present)  - Muscle twitches/ Spasms (Nov 2021 - present) - intolerance to all alcohol and caffeine (Nov 2021- present)
FIVE HOURS AFTER VACCINATION HAD STRONG SYMPTOMS OF CONJUNCTIVITIS - RED EYES, SCRATCHY, ITCHY, DISCHARGE, PUFFED UP EYELIDS
cardiac arrest; This is a spontaneous report from a contactable consumer (patient). This 61-years-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration on an unspecified date at age of 61-years-old as dose 2, single for COVID-19 immunization.  The patient's medical history and concomitant medications were not reported.  Patient reported he received the Covid vaccine and defibrillator fired 7x's and he was life lined. After second dose Covid vaccine patient was cardioverted and following second dose Covid vaccine, patient had cardiac arrest. The outcome of the event was unknown.  Information on lot/batch number has been requested.
Sore arm the day of receiving my booster shot. That night, I was very cold and was unable to fall asleep. I was very nauseous and ended up vomiting in the middle of the night. Then again a couple hours later. The day following the booster shot, I had a slight fever with chills, body aches and was feeling general malaise. I took Tylenol to combat these symptoms. My arm was also very sore and hard to move that day and the next day. However 2 days following my booster shot I felt much better.
Pfizer COVID-19 Vaccine EUA  3/23: The patient presents with facial swelling and facial swelling. Patient a 41 y/o female with a history of HTN and anxiety presents to the Emergency Department with facial swelling in her left cheek that began today after she received her first dose of the Pfizer COVID-19 vaccine. She had a panic attack prior to getting vaccinated today. She was also feeling anxious while receiving the vaccine and states that she experienced a tingly sensation on the inside of her cheek as well as having a dry mouth. The patient denies trouble swallowing and eating, sinus pressure, shortness of breath, rashes, and dental issues. She notes that she has gone to the bathroom more frequently today but is not experiencing any diarrhea. Additionally, she has taken hydroxyzine for her symptoms. She is allergic to penicillin..  The onset was abrupt.  The course/duration of symptoms is constant.  Location: Left cheek. The character of symptoms is swelling.  The degree at present is minimal.  The exacerbating factor is none.  The relieving factor is none.  Risk factors consist of none. Prior episodes: none.  Therapy today: prescription medications including hydroxizine.  Associated symptoms: Dry mouth and tingly sensation on the inside of cheek. Associated injury none. She states she had a panic attack upon sitting down in the chair to receive her COVID shot in her left arm.  She had to take her anxiety medication there and then later in the day.  She states she felt as if the inside of her cheek was swollen and scratchy this made her very anxious and decided to come in to get checked out. She denies any hives any abdominal pain nausea vomiting shortness of breath chest pain or redness at the injection site.  She feels mildly improved from an anxiety standpoint now compared to the onset but still mildly anxious.  She has a very normal physical exam no neck tongue or lip swelling there is no redness at the injection site she has no hives abdomen is soft and tender or buccal mucosa is unremarkable ultimately patient reassured discussed it is important she get her 2nd COVID shot.  She understands return precautions for signs of allergic reaction. She received no medications.
Fever, Muscle Aches, Runny Nose, Sore throat, New Olfactory and Taste Disorder, Headache, Fatigue, Cough, Shortness of Breath, Nausea, Vomiting  and Diarrhea
Janssen COVID-19 vaccine was administered to patient and the patient immediately reported pain at injection site, change in taste, and trouble breathing. Patient began gasping for air. The patient remained aware and able to communicate. I instructed a tech to call 911 and the operator instructed me to use a dose of epinephrine. After administration, the patient's breathing improved. EMT's arrived and took over care for the patient. I informed them of the time of vaccination and the time of epinephrine administration. The patient was then taken to the hospital to receive additional care.
Tenderness to site lt arm 7x4cm ecchymosis superficial, 2.5x2.5cm subcutaneous nodule ? hematoma - no cellulitis. Office appt 8-14-07 for above.
Fever of 102F, generalized myalgias, arthralgias, allodybia, headache, photosensitivity, hyperacusis, fatigue, nausea. Symptoms slowly emerged over 12 hours and lasted for a total of 24 hours
This spontaneous report was received from a nurse refers to multiple unspecified patients of unknown age and gender. On an unknown date, the patients were vaccinated with improperly stored doses of RECOMBIVAX HB (dose, frequency, route of administration and indication were not reported, lot number# L016427 with expiration date: 13-APR-2017). This is one of the several reports received from the same reporter. Additional information has been requested.
Information has been received from a current 37 year old female pharmacist with sulfa allergy, reporting on herself, who in January 2002, when she was 27 year old, was vaccinated with a dose of VARIVAX (Merck) (dose, route and lot number were not reported). There was no concomitant medication. In January 2002, the pharmacist experienced closing of her throat, a canker sore on her uvula and a fever after receiving a dose of VARIVAX (Merck). She was working in a hospital when this reaction occurred and she was treated with PERCOCET and BENADRYL injection at that hospital triage center and released. She was not admitted to the hospital. There were no laboratory studies performed. The pharmacist reported that the throat cleared in less than 12 hours and it took longer for canker sore to heal. The patient recovered in January 2002. Closing of her throat, canker sore and a fever were considered to be immediately life-threatening by the reporter. Additional information has been requested.
mild soreness on injected arm after the first dose; This is a spontaneous report from a contactable nurse (the patient) from a Pfizer-sponsored program. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number not provided), via an unspecified route of administration in the arm on an unspecified date (age at vaccination unknown) as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient wanted to know if she could take painkillers before and after her second dose. She mentioned having mild soreness on injected arm after the first dose (unspecified date). The patient had one dose of the Pfizer-BioNTech COVID-19 Vaccine and didn't take any pain killers. She just had a slightly sore arm. She heard something about the second dose can give you a headache. She asked what was recommended on taking pain medication like acetaminophen, ibuprofen, or diphenhydramine hcl (BENADRYL) before and/or after vaccination? The clinical outcome of mild soreness on injected arm after the first dose was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021101338 Pfizer
slight soreness of the arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (slight soreness of the arm) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 03-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 03-Feb-2021, the patient experienced VACCINATION SITE PAIN (slight soreness of the arm). At the time of the report, VACCINATION SITE PAIN (slight soreness of the arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided.  Treatment medications were not provided.   Reporter did not allow further contact
Case number PHEH2015US017659, is an initial spontaneous report from a nurse received on 09 Sep 2015. This report refers to a 53 year old male patient. Medical history was not reported. Vaccination history included administration of FLUVIRIN (batch number: not reported) two times and the patient tolerated those vaccinations. Concomitant medications was not reported. The patient was vaccinated with FLUVIRIN (batch number: 157103) intramuscularly at a dose of 0.5 ml into left deltoid on 08 Sep 2015 at 13:40 hour. It was reported that patient received an out of temperature range FLUVIRIN which was stored at a temperature range of 33.2 degree Fahrenheit. No adverse event reported following this medication error.
C/O constant dizziness since 2 hours after shot given, HA, no fever. TYLENOL with relief of HA.
it was rpt fr HCP concerning pt who was vax & subsequently pt exp chickenpox outbreak of 15 small lesions that are sm & not highly fluid filled.
body cramps, chills, fever inc 105, h/a, throat hurt, perspiring, body aches;
This spontaneous report as received from a medical assistant and refers to a patient of unknown age and gender. The patient's medical history and current conditions were not provided. On 13-MAY-2016, the patient was inadvertently vaccinated with an expired dose of PROQUAD (Merck) (dose and route were not reported) lot # K007801, expiration date 29-NOV-2015. No adverse experience has been reported. This is one of several reports received from the same reporter. Additional information has been requested.
patient called EMS with pain crisis and noted that she had lost vision in both eyes. was transported to Emergency room by EMS and had cardiac arrest and died.
Pt. states developed hives on right arm, no hives reported on any other location of the body
This spontaneous report was received from a registered nurse concerning a patient of unknown age and gender. On 09-SEP-2013 the patient was vaccinated with dose 1 of RECOMBIVAX HB (10 microgram per milliliter of strength) (lot number, expiry date and dose unspecified), intramuscularly. On 11-SEP-2013 the patient was vaccinated with an additional dose (dose 2) of RECOMBIVAX HB) (10 microgram per milliliter of strength) (lot number, expiry date and dose unspecified), intramuscularly. No concomitant therapy was reported. No adverse effects were reported. Additional information has been requested.
Patient reports severe pain in left arm originating at the site of injection and shooting pains traveling down left arm from original site of injection.  Denies redness or swelling.  This started at about 2:00 a.m. on this date.  Patient is taking ibuprofen every 4-6 hours.  Mild relief obtained from this.  Patient told to apply cold compresses to arm and to contact her physician if no relief is felt by tomorrow morning.
Numbness, Tingling (Pins & Needles) in feet and legs. Toes pale and cold feeling also cold  to the touch, unable to be warmed up using any conventional route (Warm water, additional layers, heating pad etc.). Occurred in an hour of vaccine and continued on throughout the night. Symptoms resolved within 24 hours of onset.
Started my period 2 weeks early; skipped a fertility cycle; headache; sore arm
Soreness; Headache; Light Headed; Difficulty Breathing; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Soreness), HEADACHE (Headache), DIZZINESS (Light Headed) and DYSPNOEA (Difficulty Breathing) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 04-Feb-2021, the patient experienced MYALGIA (Soreness), HEADACHE (Headache), DIZZINESS (Light Headed) and DYSPNOEA (Difficulty Breathing). At the time of the report, MYALGIA (Soreness), HEADACHE (Headache), DIZZINESS (Light Headed) and DYSPNOEA (Difficulty Breathing) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported.  No treatment information was provided.  The patient's medical history included DIAGNOSES OF CANCER TWICE as well as the DOUBLE FLU   Most recent FOLLOW-UP information incorporated above includes: On 21-May-2021: Follow up report included: Patient stated that after receiving the vaccine had covid and has lost sense of smell and taste. Declined FU stating "wants to put everything behind her"
Flu like symptoms/ I'm feeling flu-like; I'm feeling flu-like, feverish, fatigue, feeling flushed, achy all over/Was fevered; I'm feeling flu-like, feverish, fatigue, feeling flushed, achy all over; I'm feeling flu-like, feverish, fatigue, feeling flushed, achy all over; I'm feeling flu-like, feverish, fatigue, feeling flushed, achy all over; A mild headache; Being dizzy; Nausea; Overwhelming feeling of being sick.; Feeling poorly.; This is a spontaneous report from a contactable consumer (patient). A 51-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) lot number: EL3246, expiration date: 30Apr2021, route of administration unknown injection to left arm at 8:45 am on 02Jan2021 at single dose for COVID-19 immunization. Medical history and concomitant medications were reported as none. It was reported that patient was administered her first dose of Pfizer BioNTech COVID-19 Vaccine 02Jan2021. She began to have flu like symptoms within like an hour of being administered that first dose. She asked how long she could expect these symptoms to last; because everything she has read said they usually last like 2-3 days. Flu like symptoms: Event started as a mild headache that she took paracetamol (TYLENOL) for to ward off. By the next day: 03Jan2021 she could not get out of bed, was fevered taking ibuprofen (MOTRIN) or paracetamol (TYLENOL) around the clock to treat symptoms described as negative effects. She had onset of headaches, being dizzy, nausea, overwhelming feeling of being sick. It is almost like time release; she will feel like she is getting better and almost ok and then will be getting sick again. She is still feeling poorly. She probably will not get the scheduled second dose of vaccine because she is absolutely terrified of getting it; they say the second dose is supposed to be worse than the first dose; and if it is she will probably be bedbound if she gets the second dose. She has never had any reactions to any vaccinations including flu vaccine that she has gotten every year. Patient further stated that she had the COVID vaccine and felt sick. She was feeling flu-like, feverish, fatigue, feeling flushed, achy all over and had been in bed for a couple days. Patient wanted to know if a booster dose will be necessary in the future. Patient had not recovered from flu like symptoms, while outcome of the other mentioned events was unknown.
Patient 16 years old at time of vaccine which Jansen Covid vaccine to be given to 18 years and older. Patient's date of birth on the covid card is incorrect.
Flushing/sweating, dizzy. History of fainting with shots. BPs 154/92, 121/74 (pulse 52). O2 sats 97%, 100%.
Headaches; Lightheadedness; Vomiting alone; Wheezing; Weak couldn't walk.
Took a dose from J&J, then took a Moderna full dose; This spontaneous case was reported by a consumer and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Took a dose from J&J, then took a Moderna full dose) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included OMEPRAZOLE for an unknown indication.    On 10-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 10-Oct-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Took a dose from J&J, then took a Moderna full dose). On 10-Oct-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Took a dose from J&J, then took a Moderna full dose) had resolved.            Concomitant medication was not reported. Treatment information was not reported.  Patient reports they took a J&J vaccine back on 07Apr2021,Batch number 203A21A
Myalgia, Fever & NauseaVomiting Narrative: MISSED WORK DUE TO SYMPTOMS